Schedule 13G ownership disclosure

Verastem Inc

Common Stock · CUSIP: 92337C203

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Soleus Private Equity Fund III, L.P.

    Shares: 1,786,129.00 · Class: 3.9%

  • Soleus Private Equity GP III, LLC

    Shares: 1,786,129.00 · Class: 3.9%

  • Soleus PE GP III, LLC

    Shares: 1,786,129.00 · Class: 3.9%

  • Soleus Capital Master Fund, L.P.

    Shares: 1,564,563.00 · Class: 3.5%

  • Soleus Capital, LLC

    Shares: 1,564,563.00 · Class: 3.5%

  • Soleus Capital Group, LLC

    Shares: 1,564,563.00 · Class: 3.5%

  • Soleus Capital Management, L.P.

    Shares: 3,350,692.00 · Class: 7.3%

  • Soleus GP LLC

    Shares: 3,350,692.00 · Class: 7.3%

  • Guy Levy

    Shares: 3,350,692.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-012190
Form type
SCHEDULE 13G/A
Filer
Soleus Capital Master Fund, L.P.
CIK
CIK 1812275
Filed
Feb 11, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub